Cyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic Melanoma
Clinical trial NCT00096382 · COMPLETED
Trial details
- NCT number
- NCT00096382
- Sponsor
- National Institutes of Health Clinical Center (CC)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2009-01-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.